CME Group Inc.
274.70USD
-3.5300 (-1.27%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.94▼ | $2.97 | 4 | 7 |
| Next quarter | $2.96▼ | $2.96 | 7 | 3 |
| Current year | $12.25▼ | $12.27 | 14 | 1 |
| Next year | $12.91▲ | $12.91 | 12 | 2 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.91 | $2.99 | +0.08 (+2.8%) |
| 2026-03-31 | $3.37 | $3.36 | -0.01 (-0.3%) |
| 2025-12-31 | $2.74 | $2.77 | +0.03 (+1.0%) |
| 2025-09-30 | $2.63 | $2.68 | +0.05 (+2.0%) |
383 ratings from 37 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Reiterated | Buy | $292 | Sep 3, 2026 |
| Deutsche Bank | Downgraded from Buy | Hold | $286 $270 | Aug 19, 2026 |
| JP Morgan | Maintained | Underweight | $249 $250 | Jul 23, 2026 |
| B of A Securities | Maintained | Underperform | $226 $230 | Jul 23, 2026 |
| Morgan Stanley | Maintained | Overweight | $324 $330 | Jul 23, 2026 |
| Piper Sandler | Maintained | Overweight | $329 $295 | Jul 15, 2026 |
| Morgan Stanley | Maintained | Overweight | $353 $324 | Jul 10, 2026 |
| Barclays | Maintained | Equal-Weight | $316 $270 | Jul 9, 2026 |
| TD Cowen | Maintained | Buy | $273 $270 | Jul 8, 2026 |
| UBS | Maintained | Neutral | $310 $260 | Jul 6, 2026 |
| Raymond James | Reiterated | Outperform | $320 | Jul 2, 2026 |
| TD Cowen | Maintained | Buy | $323 $273 | Jun 22, 2026 |
| Keefe, Bruyette & Woods | Upgraded from Market Perform | Outperform | $305 | Jun 18, 2026 |
| Rothschild & Co | Upgraded from Neutral | Buy | $316 $323 | Jun 11, 2026 |
| Erste Group | Downgraded from Buy | Hold | — | Jun 5, 2026 |
| Morgan Stanley | Maintained | Overweight | $362 $353 | Apr 23, 2026 |
| Barclays | Maintained | Equal-Weight | $343 $316 | Apr 23, 2026 |
| TD Cowen | Maintained | Buy | $340 $323 | Apr 23, 2026 |
| Piper Sandler | Maintained | Overweight | $313 $329 | Apr 15, 2026 |
| Barclays | Maintained | Equal-Weight | $344 $343 | Apr 13, 2026 |
| Morgan Stanley | Maintained | Overweight | $340 $362 | Apr 10, 2026 |
| TD Cowen | Maintained | Buy | $328 $340 | Apr 9, 2026 |
| Barclays | Maintained | Equal-Weight | $312 $344 | Apr 8, 2026 |
| Argus Research | Downgraded from Buy | Hold | — | Mar 4, 2026 |
| UBS | Maintained | Neutral | $280 $310 | Feb 6, 2026 |
134 filings from 32 insiders · 32 buy / 5 sell over 6m
Officers and directors of CME, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| SHEPARD WILLIAM RDirector | Buy | 339 | $230.57 | $78k | Jun 25, 2026 |
| COOK ELIZABETH ADirector | Grantindirect | 645 | $225.00 | $145k | Jun 25, 2026 |
| HOBERT WILLIAM WDirector | Grant | 1.1k | $225.00 | $240k | Jun 25, 2026 |
| BENESH KATHRYNDirector | Grant | 645 | $225.00 | $145k | Jun 25, 2026 |
| LOCKETT PHYLLIS MDirector | Grant | 645 | $225.00 | $145k | Jun 25, 2026 |
| FORD HAROLD EUGENE JRDirector | Grant | 1.1k | $225.00 | $240k | Jun 25, 2026 |
| MALONEY PATRICK WDirector | Grant | 645 | $225.00 | $145k | Jun 25, 2026 |
| SEIFU RAHAELDirector | Grant | 645 | $225.00 | $145k | Jun 25, 2026 |
| SIEGEL HOWARD JDirector | Grant | 1.1k | $225.00 | $240k | Jun 25, 2026 |
| TIERNEY ROBERT J. JRDirector | Grant | 645 | $225.00 | $145k | Jun 25, 2026 |
| SHEPARD WILLIAM RDirector | Grant | 1.1k | $225.00 | $240k | Jun 25, 2026 |
| MULCHRONE PATRICK JDirector | Grant | 645 | $225.00 | $145k | Jun 25, 2026 |
| BITSBERGER TIMOTHY SDirector | Grant | 645 | $225.00 | $145k | Jun 25, 2026 |
| GEPSMAN MARTIN JDirector | Grant | 645 | $225.00 | $145k | Jun 25, 2026 |
| SUSKIND DENNIS A.Director | Grant | 645 | $225.00 | $145k | Jun 25, 2026 |
| CAREY CHARLES PDirector | Grantindirect | 1.1k | $225.00 | $240k | Jun 25, 2026 |
| DURKIN BRYAN TDirector | Grant | 645 | $225.00 | $145k | Jun 25, 2026 |
| LUCAS DEBORAH JDirector | Grant | 645 | $225.00 | $145k | Jun 25, 2026 |
| KAYE DANIEL GDirector | Grant | 645 | $225.00 | $145k | Jun 25, 2026 |
| PIELL HILDA HARRISOfficer | Sell | 5.8k | $304.63 | $1.75M | May 18, 2026 |
No analyst notes on CME yet.
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 3 | 6 | 1 | 2 | Hold2.63 |
| 1 mo ago | 4 | 3 | 6 | 1 | 2 | Hold2.63 |
| 2 mo ago | 5 | 4 | 4 | 1 | 2 | Buy2.44 |
| 3 mo ago | 4 | 5 | 4 | 1 | 2 | Hold2.50 |